Tolerability and safety of Octagam(®) (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials

Objective: To evaluate the tolerability and safety of Octagam(®) 5% and 10% across all indications, ages, and treatment regimens, using data from four non-interventional post-authorization safety studies (PASS); this analysis was performed following changes in the preparation of raw material used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Frenzel, Wolfgang, Wietek, Stefan, Svae, Tor-Einar, Debes, Anette, Svorc, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095453/
https://www.ncbi.nlm.nih.gov/pubmed/27719744
http://dx.doi.org/10.5414/CP202782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095453/
https://www.ncbi.nlm.nih.gov/pubmed/27719744
http://dx.doi.org/10.5414/CP202782

Ejemplares similares